Company Overview
Pharmaceutical development invariant Natural Killer T (iNKT) cell platform for cancer treatment and its oral spray delivery technology to treat cancer and conditions that affect the central nervous system.
Website | www.arovella.com |
---|---|
Head Office | Osborne Park WA |
Registry | Automic Pty Ltd |
CEO | Michael Baker |
Chair Person | Elizabeth Stoner |
GICS Industry | Pharmaceuticals, Biotechnology & Life Sciences |
Sub Industry | Pharmaceuticals |
Sector | Health Care |
Market Cap | $24 m |
---|---|
Shares on Issue | 754 m |
Status | Trading |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
No data to display.
Top 20 Shareholders
No data to display.
Director Transactions
No data to display.